• Only pre-symptomatic breath infection technology available
• Point of care
• 5 U.S. patents with use for life of patent
• Pivotal clinical trial ready
o Established partnerships with hospitals
• 30 years of research across multiple specializations
• 10 years of technology field and commercial use, in humans and
animals
This breakthrough technology comes from the strength of over a decade of research and an exclusive pool of research scientists, the founders of the Isomark Canary™ technology. “Our technology was created for the early detection of infection in humans. It was tested in medical clinics and ICUs around the country,” said Dr. Fariba Assadi-Porter, Founder and CEO of Isomark. Using this powerful technology as a simple screening device will be the key to the future of safe gatherings and social events.
The Isomark Canary Screening Device can be used to screen players by simply breathing into the Iso-straw, which is connected to the Canary machine. The test takes less than 1 minute to complete with 99% accuracy and more than 90% accuracy for players that are Asymptomatic.
It was reported by several news outlets A woman with an undiagnosed skull defect started leaking cerebral fluid out of her nose after she received a COVID-19 test administered with a nasal swab, according to a new case report.
The report, published Thursday in the journal JAMA Otolaryngology – Head & Neck Surgery, described a singularly unusual situation, where the nasal swab disturbed a mass in the woman’s nasal cavity containing cerebrospinal fluid and brain tissue.
For the patient, a woman in her 40s, it started with a COVID-19 test ahead of an elective hernia surgery. The test was done using a nasal swab that reached deep into the nasal cavity, a common form of testing for COVID-19
Our CEO S. Nalls says “The major difference between invasive and non–invasive tests is that invasive tests are done by cutting or entering a body part using medical instruments, whereas non–invasive tests do not require breaking the skin or entering the body.”
Each person participating in the screening must first register on the system. To register into the system, you must first blow into the device. This will authenticate the person and create a profile plus establish an individual baseline. Each individual has their own breath value (BDV). Isomark refers to its breath value as your individual ISO score. Isomark has a very unique and scientific method of assessing a numerical value to the stability or fluctuation of the immune system. To obtain an ISO score blow one stream of exhaled air into the ISO straw. These straws are disposable and will never be used more than once. Within 30-45 seconds a green light or red light will be aluminate. The green light indicates your ISO score is in-line or In-Range with your baseline score. You receive your baseline score at the time you register your first breath on the scanning device. If the light aluminates red, your ISO score is Out- of-Range of your baseline score, indicating you should seek additional medical attention. For the persons who show no signs and have no symptoms but are possibly still a carrier of an infection, they will be exposed within 30-45 seconds after screening.
The technology was developed to detect the early onset of infection and disease in the human body. With the ability to detect an infection within 3-4 hours of on onset remains an industry Gold-standard. This standard is 48 hours prior to any current practice available today.
The Isomark Canary technology has been tested in several major hospital ICUs, including the Cleveland Clinics, Mayo Clinics, University of Wisconsin hospital and Duke Medical Center to name a few. All testing and trial sites to date have endorsed the technology and some have even published.
Coronavirus cases have risen in 33 states and Puerto Rico since late August, and at least a dozen states have reported rising hospitalizations in recent days, according to data analyzed by The Washington Post.
The coronavirus map shows flare-ups coast to coast and from the Canadian to the Mexican border. Brooklyn is once again dealing with a spike in cases, and the state of New York on Friday reported its highest one-day case count since May 28.
New Jersey and Delaware have experienced rising numbers, as has Texas, which just recently endured a midsummer surge. Wisconsin, a critical swing state in the presidential election, has been hammered. It had logged record highs in case counts for 20 straight days as of Thursday, and recorded more than 17,000 new confirmed infections in a single week.
Who created the technology?
The Isomark Canary technology was developed in 2010 and registered as a company in 2012. The technology was developed by three of the most prestigious research scientists at UW, Dr. Warren Porter, the late Dr. Mark Cook, and the current CEO Dr. Fariba Assadi-Porter.
“The future existence of our churches, and events such as concerts, sporting events and banquets ect…. is why I’m so grateful. Being the first organization to introduce the Canary™ Screening device to the world is truly a blessing. Being able to assist other church organization and sports institutions, schools districts ,collages and university, factories and the list goes on and on in acquiring the Canary™ Screening device will become the future of HFCB,” said Bishop Stewart.